ClinicalTrials.Veeva

Menu

The Evolution and Management of Migraine Recurrence Beyond 24 Hours

Rowan University logo

Rowan University

Status

Completed

Conditions

Migraine

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT00754611
EN4162008

Details and patient eligibility

About

What is the course of migraine headache recurrence, how is it managed, what characteristics are associated with it, and how does it influence patient satisfaction with treatment?

Enrollment

100 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female and male patients at University Headache Center with > 6 month diagnosis of migraine with and/or without aura (ICHD-II)
  • Greater than or equal to 18 years old

Exclusion criteria

  • Greater than 15 days/month total headache days
  • Analgesic use greater than 15 days/month (other than aspirin less than or equal to 325mg/d)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems